Achievements and beyond: Scientific trajectory of Professor Mohammad A. Rafi

por Omidi, Yadollah, Alavi, Abass
Publicado 2021

Debate on human aging and lifespan

por Rafi, Mohammad A., Alavi, Abass
Publicado 2017

The critical role of FDG-PET/CT imaging in assessing systemic manifestations of COVID-19 infection

por Alavi, Abass, Werner, Thomas J., Gholamrezanezhad, Ali
Publicado 2021

Global disease score (GDS) is the name of the game!

por Høilund-Carlsen, Poul F., Edenbrandt, Lars, Alavi, Abass
Publicado 2019

Re: Aducanumab-Related ARIA: Paean or Lament?

por Høilund-Carlsen, Poul F., Alavi, Abass, Revheim, Mona-Elisabeth
Publicado 2023

Alzheimer’s Disease at a Crossroad: Time to Part from Amyloid to More Promising Aspects—Atherosclerosis for a Start

por Høilund-Carlsen, Poul F., Revheim, Mona-Elisabeth, Alavi, Abass
Publicado 2022

FDG PET/CT in carcinoma of unknown primary

por Kwee, Thomas C., Basu, Sandip, Cheng, Gang, Alavi, Abass
Publicado 2009

The value of FDG-PET/CT imaging in the assessment, monitoring, and management of COVID-19

por Griffin, Matthew T., Werner, Thomas J., Alavi, Abass, Revheim, Mona-Elisabeth
Publicado 2023

Atherosclerosis imaging with (18)F-sodium fluoride PET: state-of-the-art review

por Høilund-Carlsen, Poul F., Sturek, Michael, Alavi, Abass, Gerke, Oke
Publicado 2019

Advantages and Applications of Total-Body PET Scanning

por Katal, Sanaz, Eibschutz, Liesl S., Saboury, Babak, Gholamrezanezhad, Ali, Alavi, Abass
Publicado 2022

Cancer metastasizes to the bone marrow and not to the bone: time for a paradigm shift!

por Høilund-Carlsen, Poul Flemming, Hess, Søren, Werner, Thomas J., Alavi, Abass
Publicado 2018

FDG PET (and MRI) for Monitoring Immunotherapy in Alzheimer Disease

por Høilund-Carlsen, Poul F., Revheim, Mona-Elisabeth, Alavi, Abass, Barrio, Jorge R.
Publicado 2023

Can Target-to-Background Ratio Measurement Lead to Detection and Accurate Quantification of Atherosclerosis With FDG PET? Likely Not

por Alavi, Abass, Werner, Thomas J., Høilund-Carlsen, Poul Flemming., Revheim, Mona-Elisabeth
Publicado 2022

Aducanumab-Related Amyloid-Related Imaging Abnormalities: Paean or Lament?

por Høilund-Carlsen, Poul F., Werner, Thomas J., Alavi, Abass, Revheim, Mona-Elisabeth
Publicado 2022

The Value of Radiologic Interventions and (18)F-DOPA PET in Diagnosing and Localizing Focal Congenital Hyperinsulinism: Systematic Review and Meta-Analysis

por Blomberg, Björn A., Moghbel, Mateen C., Saboury, Babak, Stanley, Charles A., Alavi, Abass
Publicado 2012

Emerging role of radiolabeled nanoparticles as an effective diagnostic technique

por de Barros, AndréLuís Branco, Tsourkas, Andrew, Saboury, Babak, Cardoso, Valbert Nascimento, Alavi, Abass
Publicado 2012

FDG-PET/CT of COVID-19 and Other Lung Infections

por Eibschutz, Liesl S., Rabiee, Behnam, Asadollahi, Shadi, Gupta, Amit, Assadi, Majid, Alavi, Abass, Gholamrezanezhad, Ali
Publicado 2022

Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors

por Helgebostad, Rasmus, Revheim, Mona-Elisabeth, Johnsrud, Kjersti, Amlie, Kristine, Alavi, Abass, Connelly, James Patrick
Publicado 2022

Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials

por Høilund-Carlsen, Poul F., Revheim, Mona-Elisabeth, Alavi, Abass, Satyamurthy, Nagichettiar, Barrio, Jorge R.
Publicado 2022

(64)Cu-DOTATOC PET-CT in Patients with Neuroendocrine Tumors

por Mirzaei, Siroos, Revheim, Mona-Eilsabeth, Raynor, William, Zehetner, Walter, Knoll, Peter, Zandieh, Shahin, Alavi, Abass
Publicado 2019